Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study

M. Baldwin, G. Machnicki, L. Li, Z. Wei, T. C. Yu, K. H. Kahler (Horsham, West Sussex, United Kingdom; Buenos Aires, Argentina; Jiaxing, Zhejiang Province, China; East Hanover, United States Of America)

Source: International Congress 2014 – Intervening in allergic asthma
Session: Intervening in allergic asthma
Session type: Poster Discussion
Number: 3477
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Baldwin, G. Machnicki, L. Li, Z. Wei, T. C. Yu, K. H. Kahler (Horsham, West Sussex, United Kingdom; Buenos Aires, Argentina; Jiaxing, Zhejiang Province, China; East Hanover, United States Of America). Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study. Eur Respir J 2014; 44: Suppl. 58, 3477

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


REG study: Real-life, longitudinal ICS adherence patterns in a UK asthma population
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


A multidisciplinary clinic for children with severe asthma: Clinical outcomes and healthcare utilization
Source: International Congress 2014 – More paediatric asthma
Year: 2014

Prescription patterns and treatment adherence of asthma controller therapy in children in a Dutch primary care database
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013


Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
Source: International Congress 2014 – More paediatric asthma
Year: 2014

Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


The control of asthma in real life: Baseline evaluation of a long-term study
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016

LATE-BREAKING ABSTRACT: Effectiveness of individualized self management support for children with asthma in Dutch outpatient clinics, preliminary results of a randomized controlled trial.
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


An overview of patient adherence to asthma medication in Canada
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Investigation for asthma-related healthcare utilization and prescription of pregnant women with asthma in Korea
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013

The primary care routine data registry BeoNet: First pilot phase results for COPD research
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Interim analysis of post-marketing surveillance of omalizumab in Japan
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Estimating severe asthma prevalence in austria using nationwide prescription data
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015

Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Medical doctors’ knowledge, attitudes and practice patterns in asthma’s diagnosis and management in Vietnam
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013